NCT06006715 is a clinical trial in Irritable Bowel, sponsored by Aarhus University Hospital.

Who is sponsoring NCT06006715?

NCT06006715 is sponsored by Aarhus University Hospital.

What condition does NCT06006715 study?

NCT06006715 studies Irritable Bowel, Fibromyalgia, Chronic Fatigue Syndrome, Bodily Distress Syndrome, Medically Unexplained Syndrome.

Is NCT06006715 still recruiting?

NCT06006715 is currently completed. Last updated 8 September 2023.

Last reviewed 2023-09-08 · How we verify

NCT06006715

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psychiatric Disorders and Functional Somatic Disorders

Completed Last updated 8 September 2023

What this trial tests

trial in Irritable Bowel in 7,493 participants. Completed in 30 August 2022.

Timeline

10 November 2011

Primary endpoint
4 January 2021

30 August 2022

Quick facts

Lead sponsor	Aarhus University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	7,493
Start date	10 November 2011
Primary completion	4 January 2021
Estimated completion	30 August 2022

Conditions studied

Irritable Bowel — all drugs for Irritable Bowel →
Fibromyalgia — all drugs for Fibromyalgia →
Chronic Fatigue Syndrome — all drugs for Chronic Fatigue Syndrome →
Bodily Distress Syndrome — all drugs for Bodily Distress Syndrome →

Sponsor

Aarhus University Hospital

Who can join

Adults 18 to 84, any sex, with Irritable Bowel or Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objectives of this study are: Firstly, to investigate the association between psychiatric disorders and functional somatic disorder (FSD). Secondly, to investigate whether psychiatric disorders are risk factors for newly developed (incident) FSD after a 5-year follow-up period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Aarhus University Hospital trials

Trials by the same sponsor.

NCT07432802 — Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer · NA · not yet recruiting
NCT07499336 — UNDERSTANDING THE T-CELL AND B-CELL RECEPTOR REPERTOIRE IN CHILDREN AND YOUNG ADULTS WITH ANTI-DRUG ANTIBODIES AGAINST P · not yet recruiting
NCT07454486 — TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cance · not yet recruiting
NCT07284069 — Senicapoc and Perampanel for Newly Diagnosed Glioblastoma · EARLY_PHASE1 · recruiting
NCT07426250 — Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06006715 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aarhus University Hospital
Last refreshed: 8 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06006715.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing